Literature DB >> 2575628

The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis.

H A Ludlam1, A E Young, A J Berry, I Phillips.   

Abstract

We describe the control of wound infection with Staphylococcus aureus in patients undergoing continuous ambulatory peritoneal dialysis at St. Thomas' Hospital. Forty-nine percent of 61 catheters inserted in 1985 and 1986 became infected, and the majority of these infections were acquired in hospital. Infection was impossible to eradicate and was frequently associated with the subsequent development of S. aureus peritonitis, which was the most important cause of catheter loss. Strict adherence to aseptic techniques for catheter insertion and care, combined with eradication of S. aureus carriage, reduced the infection rate to 12% for the 50 catheters inserted in 1987, abolished hospital-acquired infection and reduced the S. aureus peritonitis rate tenfold, without the use of prophylactic antibiotics. S. aureus infection is a serious but avoidable complication of continuous ambulatory peritoneal dialysis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575628     DOI: 10.1016/0195-6701(89)90069-8

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  5 in total

Review 1.  Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

2.  Susceptibility testing of bacteria recovered from patients with peritonitis complicating continuous ambulatory peritoneal dialysis.

Authors:  H Ludlam; L Johnston; P Hopkins
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

3.  The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients.

Authors:  M S Dryden; H Talsania; M McCann; B D Cookson; I Phillips
Journal:  Epidemiol Infect       Date:  1992-08       Impact factor: 2.451

4.  Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein A.

Authors:  A Fattom; R Schneerson; D C Watson; W W Karakawa; D Fitzgerald; I Pastan; X Li; J Shiloach; D A Bryla; J B Robbins
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.609

Review 5.  Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a centre in South-East Asia.

Authors:  C-C Szeto; C-B Leung; K-M Chow; B C-H Kwan; M-C Law; A Y-M Wang; S-F Lui; P K-T Li
Journal:  Clin Microbiol Infect       Date:  2005-10       Impact factor: 8.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.